Literature DB >> 19941008

Validation of EQ-5D in patients with cervical cancer in Taiwan.

Hui-Chu Lang1, Linghsiang Chuang, Shiow-Ching Shun, Ching-Lin Hsieh, Chung-Fu Lan.   

Abstract

PURPOSE: The survival rate of cervical cancer is increasing due to early diagnosis and timely treatment. As a result, the availability of a valid and reliable general HRQoL is important. The purpose of this study was to evaluate the psychometric properties of the EuroQol questionnaire (EQ-5D) in patients with cervical cancer in Taiwan.
METHOD: Outpatients with cervical cancer were recruited from three medical centers across Taiwan. Test-retest reliability and ceiling effect were evaluated. Construct validity including convergent and discriminate validities were examined using the EORTC QLQ C-30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) and the clinical indicators of the functional performance assessment using the Karnofsky Performance Scale (KPS) and disease status.
RESULTS: A total of 530 patients completed the questionnaire. The intraclass correlation coefficient for the EQ-5D index was 0.83, and the Cohen's kappa values for the EQ-5D dimensions ranged from 0.54 to 0.73. The EQ-5D index and VAS scores were higher for patients with a higher KPS score and disease-free status. The EQ-5D index was strongly correlated with all EORTC QLQ-C30 functioning scales.
CONCLUSION: The EQ-5D questionnaire is reliable and valid for the assessment of health-related quality of life in patients with cervical cancer in Taiwan.

Entities:  

Mesh:

Year:  2009        PMID: 19941008     DOI: 10.1007/s00520-009-0745-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  30 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial.

Authors:  Wilbert B van den Hout; Yvette M van der Linden; Elsbeth Steenland; Ruud G J Wiggenraad; Job Kievit; Hanneke de Haes; Jan Willem H Leer
Journal:  J Natl Cancer Inst       Date:  2003-02-05       Impact factor: 13.506

3.  Correlates of cervical cancer screening among women in Taiwan.

Authors:  Su-I Hou; Maria E Fernandez; Elizabeth Baumler; Guy S Parcel; Pai-Ho Chen
Journal:  Health Care Women Int       Date:  2003 May-Jun

Review 4.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

Review 5.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

6.  Addressing Taiwan's high incidence of cervical cancer: factors associated with the Nation's low compliance with Papanicolaou screening in Taiwan.

Authors:  C-C Liao; H Y Wang; R S Lin; C-Y Hsieh; F-C Sung
Journal:  Public Health       Date:  2006-10-30       Impact factor: 2.427

7.  The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting.

Authors:  V Mor; L Laliberte; J N Morris; M Wiemann
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

8.  The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organization and functions.

Authors:  D Osoba
Journal:  Qual Life Res       Date:  1992-06       Impact factor: 4.147

9.  Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.

Authors:  G Apolone; A Filiberti; S Cifani; R Ruggiata; P Mosconi
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

10.  Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials.

Authors:  H Anderson; M K Palmer
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  18 in total

1.  Validity of EQ-5D in general population of Taiwan: results of the 2009 National Health Interview and Drug Abuse Survey of Taiwan.

Authors:  Sheng-Tsung Yu; Hsing-Yi Chang; Kai-Ping Yao; Yu-Hsuan Lin; Baai-Shyun Hurng
Journal:  Qual Life Res       Date:  2015-04-02       Impact factor: 4.147

2.  Responsiveness of the EuroQol EQ-5D and Hospital Anxiety and Depression Scale (HADS) in rheumatoid arthritis patients receiving tocilizumab.

Authors:  L Traki; S Rostom; L Tahiri; R Bahiri; T Harzy; R Abouqal; N Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2014-04-22       Impact factor: 2.980

3.  Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea.

Authors:  Seon Ha Kim; Hwa Jung Kim; Sang-Il Lee; Min-Woo Jo
Journal:  Qual Life Res       Date:  2011-09-23       Impact factor: 4.147

4.  Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.

Authors:  John N Yfantopoulos; Athanasios E Chantzaras
Journal:  Eur J Health Econ       Date:  2016-06-04

5.  Validity and reliability of the EQ-5D for cancer patients in Korea.

Authors:  Seon Ha Kim; Jung Sung Hwang; Tae Won Kim; Yong Sang Hong; Min-Woo Jo
Journal:  Support Care Cancer       Date:  2012-04-10       Impact factor: 3.603

6.  Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.

Authors:  Rahul Khanna; Krutika Jariwala; John P Bentley
Journal:  Qual Life Res       Date:  2013-04-25       Impact factor: 4.147

7.  Measuring quality of life after intensive care using the Arabic version for Morocco of the EuroQol 5 Dimensions.

Authors:  Ibtissam Khoudri; Jihane Belayachi; Tarek Dendane; Khalid Abidi; Naoufel Madani; Aicha Zekraoui; Amine Ali Zeggwagh; Redouane Abouqal
Journal:  BMC Res Notes       Date:  2012-01-22

8.  Comparing health-related quality of life of cancer patients under chemotherapy and of their caregivers.

Authors:  Ioannis Vrettos; Konstantinos Kamposioras; Nick Kontodimopoulos; Evelina Pappa; Elissavet Georgiadou; Dionysios Haritos; Angelos A Papadopoulos; Dimitris Niakas
Journal:  ScientificWorldJournal       Date:  2012-04-24

9.  Validity and reliability of EQ-5D-3L for breast cancer patients in Korea.

Authors:  Seon-Ha Kim; Min-Woo Jo; Jong-Won Lee; Hyeon-Jeong Lee; Jong Kyung Kim
Journal:  Health Qual Life Outcomes       Date:  2015-12-23       Impact factor: 3.186

10.  Patients undergoing subacute rehabilitation have accurate expectations of their health-related quality of life at discharge.

Authors:  Steven McPhail; Terry Haines
Journal:  Health Qual Life Outcomes       Date:  2012-08-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.